drugset / Trial / NCT07817134

A Study to Visualize Multi-Symptom Allergy in Adults With Seasonal Allergic Rhinitis

NCT07817134 ↗

Phase 4 Not yet recruiting 16 enrolled HALEON
NaSingle-groupOpen-labelOther

Summary

This study is designed to visualize the response to use of fluticasone propionate nasal spray (Flonase Allergy Relief) to relieve facial allergy symptoms in individuals with moderate to severe seasonal allergic rhinitis (SAR).

Timeline

Start
2026-09
Primary completion
2026-12
Completion
2026-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone propionate Other / unclassified 50 ug Intranasal